title: [Research advances in induced pluripotent stem cells].
abstract: Differentiated somatic cells can be directly reprogrammed into induced pluripotent stem (iPS) cells in vitro. Similarly to embryonic stem (ES) cells, iPS cells have pluripotency to differentiate into all cell types and capability to self-renew themselves indefinitely. Without immune rejection and ethical issues, patient-specific iPS cells promise to be an ideal tool for regenerative medicine, drug screening, and toxicity testing.
authors: State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, CAMS and PUMC, Beijing, China.
authors: Xing-ran
authors: XR
authors: Jiang
authors: Shi-xin
authors: SX
authors: Lu
mesh_terms: D006801:Humans; D057026:Induced Pluripotent Stem Cells